We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOMO
2101
Hello Group
MOMO
$850M
$4.25M ﹤0.01%
126,893
+3,587
+3% +$128K
QUAD icon
2102
Quad
QUAD
$506M
$4.25M ﹤0.01%
908,843
+237,464
+35% +$1.48M
SRDX
2103
DELISTED
Surmodics
SRDX
$4.24M ﹤0.01%
102,330
+1,562
+2% +$65.8K
MERC icon
2104
Mercer International
MERC
$33.8M
$4.22M ﹤0.01%
342,914
+55,198
+19% +$674K
AAMI
2105
Acadian Asset Management
AAMI
$3.31B
$4.22M ﹤0.01%
412,669
-5,519
-1% -$53.8K
RYTM icon
2106
Rhythm Pharmaceuticals
RYTM
$7.99B
$4.21M ﹤0.01%
183,512
+52,296
+40% +$1.16M
HLIT icon
2107
Harmonic Inc
HLIT
$1.42B
$4.21M ﹤0.01%
539,324
+14,370
+3% +$107K
FBM
2108
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$4.19M ﹤0.01%
216,672
+50,368
+30% +$967K
AAWW
2109
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$4.19M ﹤0.01%
151,909
+2,790
+2% +$69.7K
DDOG icon
2110
Datadog
DDOG
$90.6B
$4.18M ﹤0.01%
+110,725
New +$3.98M
MELI icon
2111
Mercado Libre
MELI
$92.7B
$4.18M ﹤0.01%
7,305
+1,820
+33% +$1.01M
MOV icon
2112
Movado Group
MOV
$796M
$4.18M ﹤0.01%
192,177
+11,121
+6% +$260K
HSKA
2113
DELISTED
Heska Corp
HSKA
$4.17M ﹤0.01%
43,474
+2,030
+5% +$176K
AMPH icon
2114
Amphastar Pharmaceuticals
AMPH
$858M
$4.17M ﹤0.01%
216,109
+3,904
+2% +$74.9K
CRWD icon
2115
CrowdStrike
CRWD
$230B
$4.17M ﹤0.01%
334,292
+9,180
+3% +$120K
EVH icon
2116
Evolent Health
EVH
$527M
$4.16M ﹤0.01%
459,908
+10,309
+2% +$83.7K
INWK
2117
DELISTED
InnerWorkings, Inc.
INWK
$4.16M ﹤0.01%
754,677
+127,600
+20% +$618K
CTRN icon
2118
Citi Trends
CTRN
$621M
$4.15M ﹤0.01%
179,558
+8,014
+5% +$156K
OLP
2119
One Liberty Properties
OLP
$537M
$4.15M ﹤0.01%
152,634
-790
-0.5% -$21.7K
MNK
2120
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4.15M ﹤0.01%
1,187,970
+317,698
+37% +$991K
WAIR
2121
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$4.15M ﹤0.01%
376,208
+6,861
+2% +$75.5K
TELL
2122
DELISTED
Tellurian Inc.
TELL
$4.14M ﹤0.01%
568,898
+9,590
+2% +$73K
FBK icon
2123
FB Financial Corp
FBK
$3.1B
$4.14M ﹤0.01%
104,505
+2,151
+2% +$82.4K
TEVA icon
2124
Teva Pharmaceuticals
TEVA
$42.6B
$4.13M ﹤0.01%
421,705
+10,735
+3% +$95.8K
RYAM icon
2125
Rayonier Advanced Materials
RYAM
$570M
$4.12M ﹤0.01%
1,071,614
+227,344
+27% +$928K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.